Environment International (Feb 2024)

Effects of long-term exposure to ambient fine particulate matter and its specific components on blood pressure and hypertension incidence

  • Li Fu,
  • Yanfei Guo,
  • Qijiong Zhu,
  • Zhiqing Chen,
  • Siwen Yu,
  • Jiahong Xu,
  • Weiling Tang,
  • Cuiling Wu,
  • Guanhao He,
  • Jianxiong Hu,
  • Fangfang Zeng,
  • Xiaomei Dong,
  • Pan Yang,
  • Ziqiang Lin,
  • Fan Wu,
  • Tao Liu,
  • Wenjun Ma

Journal volume & issue
Vol. 184
p. 108464

Abstract

Read online

Background: Epidemiological evidence on the association of PM2.5 (particulate matter with aerodynamic diameter ≤ 2.5 μm) and its specific components with hypertension and blood pressure is limited. Methods: We applied information of participants from the World Health Organization's (WHO) Study on Global Ageing and Adult Health (SAGE) to estimate the associations of long-term PM2.5 mass and its chemical components exposure with blood pressure (BP) and hypertension incidence in Chinese adults ≥ 50 years during 2007–2018. Generalized linear mixed model and Cox proportional hazard model were applied to investigate the effects of PM2.5 mass and its chemical components on the incidence of hypertension and BP, respectively. Results: Each interquartile range (IQR = 16.80 μg/m3) increase in the one-year average of PM2.5 mass concentration was associated with a 17 % increase in the risk of hypertension (HR = 1.17, 95 % CI: 1.10, 1.24), and the population attributable fraction (PAF) was 23.44 % (95 % CI: 14.69 %, 31.55 %). Each IQR μg/m3 increase in PM2.5 exposure was also related to increases of systolic blood pressure (SBP) by 2.54 mmHg (95 % CI:1.99, 3.10), and of diastolic blood pressure (DBP) by 1.36 mmHg (95 % CI: 1.04, 1.68). Additionally, the chemical components of SO42−, NO3−, NH4+, OM, and BC were also positively associated with an increased risk of hypertension incidence and elevated blood pressure. Conclusions: These results indicate that long-term exposure to PM2.5 mass and its specific components may be major drivers of escalation in hypertension diseases.

Keywords